Boston Scientific (BSX) Stock Forecast & Price Target
BSX Analyst Ratings
Moderate Buy
14Buy7Hold0Sell
Based on 21 analysts giving stock ratings to Boston Scientific in the past 3 months
BSX Stock 12 Month Forecast
Average Price Target
MXN 941.28â–²(19.27% Upside)Based on 21 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is MXN 941.28 with a high forecast of MXN 1,132.93 and a low forecast of MXN 830.82. The average price target represents a 19.27% change from the last price of MXN 789.20.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 1.13K
AverageMXN 941.28
LowMXN 830.82
Highest Price TargetHighestMXN 1,132.93Average Price TargetMXN 941.28Lowest Price TargetLowestMXN 830.82
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Christopher Pasquale | Barclays | MXN 906.34→MXN 849.70 | hold | 7.67%Upside | Reiterated | 10/30/26 | ||
| Josh Jennings | TD Cowen | MXN 1,057.40→MXN 868.58 | hold | 10.06%Upside | Downgraded | 10/30/26 | ||
| Travis Steed | Bank of America Securities | MXN 1,019.64 | buy | 29.20%Upside | Reiterated | 10/30/26 | ||
| Mike Kratky | Leerink Partners | MXN 1,038.52→MXN 944.11 | buy | 19.63%Upside | Reiterated | 10/29/26 | ||
| David Rescott | Robert W. Baird | MXN 944.11→MXN 962.99 | buy | 22.02%Upside | Reiterated | 10/29/26 | ||
| Suraj Kalia | Oppenheimer | ― | hold | ― | Downgraded | 10/29/26 | ||
| Joanne Wuensch | Citi | MXN 906.34→MXN 830.82 | hold | 5.27%Upside | Assigned | 10/29/26 | ||
| Anthony Petrone | Mizuho Securities | MXN 1,038.52→MXN 944.11 | buy | 19.63%Upside | Reiterated | 10/29/26 | ||
| William Plovanic | Canaccord Genuity | MXN 1,246.22→MXN 906.34 | buy | 14.84%Upside | Reiterated | 10/29/26 | ||
| Lee Hambright | Bernstein | MXN 1,019.64→MXN 925.23 | buy | 17.24%Upside | Reiterated | 10/29/26 | ||
| Patrick Wood | UBS | MXN 1,265.11→MXN 1,076.28 | buy | 36.38%Upside | Assigned | 10/29/26 | ||
| Pito Chickering | Deutsche Bank | MXN 1,132.93→MXN 906.34 | buy | 14.84%Upside | Reiterated | 10/29/26 | ||
| Michael Matson | Needham | MXN 1,076.28→MXN 906.34 | buy | 14.84%Upside | Reiterated | 10/28/26 | ||
| Robbie Marcus | J.P. Morgan | MXN 868.58 | hold | 10.06%Upside | Downgraded | 10/28/26 | ||
| Matthew Taylor | Jefferies | MXN 1,132.93→MXN 868.58 | hold | 10.06%Upside | Downgraded | 10/28/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Christopher Pasquale | 10/30/26 | MXN 906.34→MXN 849.70 | hold | 7.67%Upside | Reiterated | Barclays | ||
| Josh Jennings | 10/30/26 | MXN 1,057.40→MXN 868.58 | hold | 10.06%Upside | Downgraded | TD Cowen | ||
| Travis Steed | 10/30/26 | MXN 1,019.64 | buy | 29.20%Upside | Reiterated | Bank of America Securities | ||
| Mike Kratky | 10/29/26 | MXN 1,038.52→MXN 944.11 | buy | 19.63%Upside | Reiterated | Leerink Partners | ||
| David Rescott | 10/29/26 | MXN 944.11→MXN 962.99 | buy | 22.02%Upside | Reiterated | Robert W. Baird | ||
| Suraj Kalia | 10/29/26 | ― | hold | ― | Downgraded | Oppenheimer | ||
| Joanne Wuensch | 10/29/26 | MXN 906.34→MXN 830.82 | hold | 5.27%Upside | Assigned | Citi | ||
| Anthony Petrone | 10/29/26 | MXN 1,038.52→MXN 944.11 | buy | 19.63%Upside | Reiterated | Mizuho Securities | ||
| William Plovanic | 10/29/26 | MXN 1,246.22→MXN 906.34 | buy | 14.84%Upside | Reiterated | Canaccord Genuity | ||
| Lee Hambright | 10/29/26 | MXN 1,019.64→MXN 925.23 | buy | 17.24%Upside | Reiterated | Bernstein | ||
| Patrick Wood | 10/29/26 | MXN 1,265.11→MXN 1,076.28 | buy | 36.38%Upside | Assigned | UBS | ||
| Pito Chickering | 10/29/26 | MXN 1,132.93→MXN 906.34 | buy | 14.84%Upside | Reiterated | Deutsche Bank | ||
| Michael Matson | 10/28/26 | MXN 1,076.28→MXN 906.34 | buy | 14.84%Upside | Reiterated | Needham | ||
| Robbie Marcus | 10/28/26 | MXN 868.58 | hold | 10.06%Upside | Downgraded | J.P. Morgan | ||
| Matthew Taylor | 10/28/26 | MXN 1,132.93→MXN 868.58 | hold | 10.06%Upside | Downgraded | Jefferies |
Stocks with the Highest Top Analyst Consensus in the General Sector
Best Analysts Covering Boston Scientific
3 Months
Success Rate34/53 ratings generated profit
64%
Average Return
+3.21%
Copying Jayson Bedford's trades and holding each position for 3 Months would result in 64.15% of your transactions generating a profit, with an average return of +3.21% per trade.
1 Year
Success Rate39/53 ratings generated profit
74%
Average Return
+12.11%
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 73.58% of your transactions generating a profit, with an average return of +12.11% per trade.
2 Years
Success Rate41/53 ratings generated profit
77%
Average Return
+22.73%
Copying Jayson Bedford's trades and holding each position for 2 Years would result in 77.36% of your transactions generating a profit, with an average return of +22.73% per trade.
BSX Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 25 | 18 | 8 | 7 | 1 |
| Buy | 45 | 47 | 41 | 39 | 37 |
| Hold | 3 | 4 | 2 | 4 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 73 | 69 | 51 | 50 | 48 |
In the current month, BSX has received 38 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. BSX average Analyst price target in the past 3 months is 941.28.
BSX Financial Forecast
HighMXN 15.65
ConsensusMXN 14.69
LowMXN 14.54
BSX Earnings Forecast
Next quarter’s earnings estimate for BSX is MXN 14.69 with a range of MXN 14.54 to MXN 15.65. The previous quarter’s EPS was MXN 13.78. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
HighMXN 103B
ConsensusMXN 98.1B
LowMXN 97B
BSX Sales Forecast
Next quarter’s sales forecast for BSX is MXN 98.15B with a range of MXN 97.04B to MXN 103.30B. The previous quarter’s sales results were MXN 97.02B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
BSX Stock Forecast FAQ
What is MX:BSX’s average 12-month price target, according to analysts?
Based on analyst ratings, Boston Scientific’s 12-month average price target is Mex$941.28.
What is MX:BSX’s upside potential, based on the analysts’ average price target?
Boston Scientific has 19.27% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Boston Scientific a Buy, Sell or Hold?
Boston Scientific has a consensus rating of Moderate Buy, which is based on 14 buy ratings, 7 hold ratings and 0 sell ratings.
What is Boston Scientific’s share price target?
The average share price target for Boston Scientific is Mex$941.28. This is based on 21 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$1,132.93, and the lowest forecast is Mex$830.82. The average share price target represents a 19.27% increase from the current price of Mex$789.2.
What do analysts say about Boston Scientific?
Boston Scientific’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 21 Wall Street analysts.
How can I buy shares of Boston Scientific?
To buy shares of MX:BSX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.